2010 China Materials Export is expected to maintain growth
Release time: 2010-04-13 & nbsp & nbsp & nbsp Source:
More than 7,100 pharmaceutical manufacturers currently registered in my country，More than 4,000 have passed GMP certification，More than 1,600 raw and drug manufacturers registered by the State Food and Drug Administration，There are more than 3700 raw materials obtained by GMP certification。
In recent years，The rapid development of the pharmaceutical industry in my country，As the largest supplier in the world as an raw medicine and medicine intermediate，China has established its firm international status。
In 2009, the total output value of my country's pharmaceutical industry reached 940.3 billion yuan，increased by 21%year -on -year。From the perspective of production，my country can produce more than 1,500 chemicals and medicines，Production capacity of more than 2 million tons，About 1/5 of global output。In recent years，The raw and drug industry has maintained a steady growth rate，The annual growth rate of output is above 10%，It has become the pillar of my country's pharmaceutical industry。From the perspective of exports，More than half of the exports of medical and health products in my country are raw and drug products。From 2002 to 2008，The average annual growth rate of the export of raw materials in my country is above 24%，Only affected by the financial crisis in 2009，The export amount has decreased，but still reached 16.559 billion US dollars。
2009，The total import and export of Chinese raw materials and drugs is 24.271 billion U.S. dollars，increased by 2.89 % year -on -year，accounting for 45.67 % of the total import and export of my medicine。Where，The export value stake betting appstake betting appis 16.559 billion US dollars，fell 4.53%year -on -year; the import value was US $ 7.713 billion，increased by 23.46%year -on -year。Under the profound influence of the financial crisis，Unremitting efforts through the pharmaceutical industry and enterprises，Export volume remained 6.90%increase，But the fierce market competition and the shrinking of the key market economy have brought a decline in price，Eventually leading to the first decline in the export value for nearly ten years。
In 2009，increased by 5.49%year -on -year。Among them, 367 are available for more than $ 10 million in annual exports，Zhejiang Pharmaceutical Co., Ltd.、Vitamin Pharmaceutical Industry、Zhejiang Provincial Pharmaceutical Health Products Import and Export Co., Ltd.、Northeast Pharmaceutical General Plant、Jiangsu Jiangshan Pharmaceutical Co., Ltd.、Zhuhai Federal Pharmaceutical Co., Ltd.、Hebei Wilkang Pharmaceutical Co., Ltd. and other 13 companies have annual exports of more than $ 100 million。Among the 13 companies with an export value of more than $ 100 million，11 companies have increased exports，and 4 companies increased more than 30%，This reflects under the conditions of the financial crisis，The growth status of the main enterprise is still good。
2009，China's raw materials export to 181 countries and regions，The key export market is Asia、Europe and North America，The export value of the three major export markets accounts for 87.4%of the export of all raw materials。Where，The export volume of the Asian market increased by 14%year -on -year，The export value increases slightly，The export volume and export volume in the European and American market have declined，But the market share has not changed much，Fall is only about 1%。African market is developing fast，Export value increases more than 14%，The increase in exports is more than 30%，The increase in exports in Latin America also reached more than 30%，This shows that the financial crisis has a greater impact on developed countries，And developing countries and emerging markets are relatively small。
From 2009，China Materials Export Market Stable，Asia and Europe and the United States account for more than 85%，The top 10 export destination countries in the ranking are developed countries，Only India and Brazil in developing countries，accounting for more than 60%of the total export value of the raw medicine。Affected by the financial stake sports betting appMy stake betting appcrisis，The pharmaceutical market of developed countries has shrunk，beauty、Day、Lotus、Italia、Bi、The export volume of 6 countries in the West has declined，Among them, the decline in the United States has reached more than 20%，The export volume of India and Brazil for emerging markets continues to grow，Among them, the export volume to India has increased by more than 40%。At the same time，Due to the decline in exports of pharmaceutical products due to the financial crisis，Domestic enterprises to adapt to the economic policy of expanding domestic demand，Developed import business。2009，China Western Pharmaceuticals and Pharmaceuticals imported 7.713 billion U.S. dollars，increased by 23.46%year -on -year，The main import market is still Japan、The United States、Korea、Belgium and Taiwan，More than 46%of the proportion of imported from my raw materials。
Rich material produced in China，The international market demand of the commodity and drug drug is strong，Large export volume，and mainly concentrated in amino acids and its derivatives、antibiotics、Anti -heat and analgesic、Anti -infection、Vitamin、hormone、Cardiovascular system class、Central nervous system class and plant extracts，The export volume in 2009 is more than $ 400 million。In addition，Special raw materials and drugs have also developed rapidly in recent years，Among them, all the category、Puli、Satan category、喹 Nonone and anti -tumor categories have become strategic choices for enterprise product upgrades and value chain upgrades。
In recent years，With the intensification of competition in the ray and drug industry，Chinese raw materials companies have begun to transform from the production of high -end low -end intermediates to fine high -end products，Continuously extend and transfer to downstream supply chain，Domestic deep processing capabilities are gradually increasing。At the same time，Domestic enterprises have also begun to actively obtain international certification，The quality of the raw and medicine has also been greatly improved。As of September 12, 2009，The number of COS certificates certified by European EDQM certification in China is 206，and as of January 12, 2010，The number of DMF files registered in the US FDA in the United States also reached 674。
Although the advantages of Chinese raw materials in the international market are more obvious，But from Stake Sports Bettingstake betting appthe operation of 2009，There are still many obstacles and deficiencies in the development of my country's raw materials。First，The haze of the financial crisis has not been dispersed，International purchasing power improves slowly，In the short term, China's raw and drug sales will not increase too much。Next，The currency depreciation of the main export destination country and competitors country，and the pressure of the appreciation of the renminbi，reduced the price competitiveness of China's raw materials in the international market，Increasing export difficulty。Third，The financial crisis prompts the intensification of trade protectionism，International trade barriers and intellectual property disputes to further deteriorate China's export market environment。Fourth，Some drug quality events seriously affect the international reputation of my country's raw materials，Negative impact on my export。Fourth，International oil prices continue to rise，The price of raw and auxiliary materials rises，Grain shorts，Environmental pressure derived from overcapacity，New Pharmacopoea、The implementation of the new GMP, etc., has increased the investment of the enterprise，The production cost of the raw drugs was added。Fifth，Europe and the United States Implementation of Materials Supply Chain Management，Strengthen GMP review and execution strength，The threshold for the export of my raw materials。Fifth，Compared with India，Chinese raw materials enterprise in DMF file、COS certification and CGMP authentication are weak，and lacks the cultivation of the international marketing and series of products of raw and drugs。All these，All will have a certain adverse effect on the export of Chinese raw materials in 2010。
Although facing many challenges，We are still very optimistic about the development prospects of Chinese raw materials，Confidence is still firm。First，2010 global pharmaceutical market value will increase by 4 ~ 6%，The growth rate of the emerging pharmaceutical market is expected to reach 12 ~ 14%，and the growth rate of the Chinese pharmaceutical market may exceed 20%。Next，Encourage the use of generic drugs around the world，Bomb -level drug patents gradually expire，Non -patented raw materials market booms，All provide development opportunities for China, which dominate the imitation API。Third，In the next stake sports betting appfour stake sports betting appyears，China、India、Latin America and Central and Eastern Europe's demand for imitation raw drugs will increase with an average compound growth rate of more than 14%，This provides huge growth opportunities for China as China, which is the world's largest generic drug producer.。Fourth，Many raw materials in China occupy a high market share in the international market，Obvious scale of scale，In the short term, other countries cannot replace。Fifth，China's production and labor costs and relative advantages，Complete category mature manufacturing technology and sufficient technology talent resources，It laid a sufficient foundation for the continuous development of Chinese raw materials and medicines。Sixth，Chinese companies avoid homogenization competition，The efforts of developing characteristic raw materials，and many companies aim at the market of developed countries，Actively pass the high -end market certification，Practice to continuously improve the quality of export products，The export space of Chinese raw materials will be expanded。
In short，2010，China's raw and drug opportunities and challenges co -deposited，But with the continuous recovery of the world economy，and the continuous introduction and implementation of the country's encouragement of export policies，We expect，2010 Chinese raw material exports may maintain a growth of about 15%。
The development of Chinese raw materials is always full of hope，The Medical Insurance Chamber of Commerce will continue to strengthen coordination and service，To promote the sustainable and healthy development of the production and trade of China's raw materials。
In recent years，The rapid development of the pharmaceutical industry in my country，As the largest supplier in the world as an raw medicine and medicine intermediate，China has established its firm international status。
In 2009, the total output value of my country's pharmaceutical industry reached 940.3 billion yuan，increased by 21%year -on -year。From the perspective of production，my country can produce more than 1,500 chemicals and medicines，Production capacity of more than 2 million tons，About 1/5 of global output。In recent years，The raw and drug industry has maintained a steady growth rate，The annual growth rate of output is above 10%，It has become the pillar of my country's pharmaceutical industry。From the perspective of exports，More than half of the exports of medical and health products in my country are raw and drug products。From 2002 to 2008，The average annual growth rate of the export of raw materials in my country is above 24%，Only affected by the financial crisis in 2009，The export amount has decreased，but still reached 16.559 billion US dollars。
2009，The total import and export of Chinese raw materials and drugs is 24.271 billion U.S. dollars，increased by 2.89 % year -on -year，accounting for 45.67 % of the total import and export of my medicine。Where，The export value stake betting appstake betting appis 16.559 billion US dollars，fell 4.53%year -on -year; the import value was US $ 7.713 billion，increased by 23.46%year -on -year。Under the profound influence of the financial crisis，Unremitting efforts through the pharmaceutical industry and enterprises，Export volume remained 6.90%increase，But the fierce market competition and the shrinking of the key market economy have brought a decline in price，Eventually leading to the first decline in the export value for nearly ten years。
In 2009，increased by 5.49%year -on -year。Among them, 367 are available for more than $ 10 million in annual exports，Zhejiang Pharmaceutical Co., Ltd.、Vitamin Pharmaceutical Industry、Zhejiang Provincial Pharmaceutical Health Products Import and Export Co., Ltd.、Northeast Pharmaceutical General Plant、Jiangsu Jiangshan Pharmaceutical Co., Ltd.、Zhuhai Federal Pharmaceutical Co., Ltd.、Hebei Wilkang Pharmaceutical Co., Ltd. and other 13 companies have annual exports of more than $ 100 million。Among the 13 companies with an export value of more than $ 100 million，11 companies have increased exports，and 4 companies increased more than 30%，This reflects under the conditions of the financial crisis，The growth status of the main enterprise is still good。
2009，China's raw materials export to 181 countries and regions，The key export market is Asia、Europe and North America，The export value of the three major export markets accounts for 87.4%of the export of all raw materials。Where，The export volume of the Asian market increased by 14%year -on -year，The export value increases slightly，The export volume and export volume in the European and American market have declined，But the market share has not changed much，Fall is only about 1%。African market is developing fast，Export value increases more than 14%，The increase in exports is more than 30%，The increase in exports in Latin America also reached more than 30%，This shows that the financial crisis has a greater impact on developed countries，And developing countries and emerging markets are relatively small。
From 2009，China Materials Export Market Stable，Asia and Europe and the United States account for more than 85%，The top 10 export destination countries in the ranking are developed countries，Only India and Brazil in developing countries，accounting for more than 60%of the total export value of the raw medicine。Affected by the financial stake sports betting appMy stake betting appcrisis，The pharmaceutical market of developed countries has shrunk，beauty、Day、Lotus、Italia、Bi、The export volume of 6 countries in the West has declined，Among them, the decline in the United States has reached more than 20%，The export volume of India and Brazil for emerging markets continues to grow，Among them, the export volume to India has increased by more than 40%。At the same time，Due to the decline in exports of pharmaceutical products due to the financial crisis，Domestic enterprises to adapt to the economic policy of expanding domestic demand，Developed import business。2009，China Western Pharmaceuticals and Pharmaceuticals imported 7.713 billion U.S. dollars，increased by 23.46%year -on -year，The main import market is still Japan、The United States、Korea、Belgium and Taiwan，More than 46%of the proportion of imported from my raw materials。
Rich material produced in China，The international market demand of the commodity and drug drug is strong，Large export volume，and mainly concentrated in amino acids and its derivatives、antibiotics、Anti -heat and analgesic、Anti -infection、Vitamin、hormone、Cardiovascular system class、Central nervous system class and plant extracts，The export volume in 2009 is more than $ 400 million。In addition，Special raw materials and drugs have also developed rapidly in recent years，Among them, all the category、Puli、Satan category、喹 Nonone and anti -tumor categories have become strategic choices for enterprise product upgrades and value chain upgrades。
In recent years，With the intensification of competition in the ray and drug industry，Chinese raw materials companies have begun to transform from the production of high -end low -end intermediates to fine high -end products，Continuously extend and transfer to downstream supply chain，Domestic deep processing capabilities are gradually increasing。At the same time，Domestic enterprises have also begun to actively obtain international certification，The quality of the raw and medicine has also been greatly improved。As of September 12, 2009，The number of COS certificates certified by European EDQM certification in China is 206，and as of January 12, 2010，The number of DMF files registered in the US FDA in the United States also reached 674。
Although the advantages of Chinese raw materials in the international market are more obvious，But from Stake Sports Bettingstake betting appthe operation of 2009，There are still many obstacles and deficiencies in the development of my country's raw materials。First，The haze of the financial crisis has not been dispersed，International purchasing power improves slowly，In the short term, China's raw and drug sales will not increase too much。Next，The currency depreciation of the main export destination country and competitors country，and the pressure of the appreciation of the renminbi，reduced the price competitiveness of China's raw materials in the international market，Increasing export difficulty。Third，The financial crisis prompts the intensification of trade protectionism，International trade barriers and intellectual property disputes to further deteriorate China's export market environment。Fourth，Some drug quality events seriously affect the international reputation of my country's raw materials，Negative impact on my export。Fourth，International oil prices continue to rise，The price of raw and auxiliary materials rises，Grain shorts，Environmental pressure derived from overcapacity，New Pharmacopoea、The implementation of the new GMP, etc., has increased the investment of the enterprise，The production cost of the raw drugs was added。Fifth，Europe and the United States Implementation of Materials Supply Chain Management，Strengthen GMP review and execution strength，The threshold for the export of my raw materials。Fifth，Compared with India，Chinese raw materials enterprise in DMF file、COS certification and CGMP authentication are weak，and lacks the cultivation of the international marketing and series of products of raw and drugs。All these，All will have a certain adverse effect on the export of Chinese raw materials in 2010。
Although facing many challenges，We are still very optimistic about the development prospects of Chinese raw materials，Confidence is still firm。First，2010 global pharmaceutical market value will increase by 4 ~ 6%，The growth rate of the emerging pharmaceutical market is expected to reach 12 ~ 14%，and the growth rate of the Chinese pharmaceutical market may exceed 20%。Next，Encourage the use of generic drugs around the world，Bomb -level drug patents gradually expire，Non -patented raw materials market booms，All provide development opportunities for China, which dominate the imitation API。Third，In the next stake sports betting appfour stake sports betting appyears，China、India、Latin America and Central and Eastern Europe's demand for imitation raw drugs will increase with an average compound growth rate of more than 14%，This provides huge growth opportunities for China as China, which is the world's largest generic drug producer.。Fourth，Many raw materials in China occupy a high market share in the international market，Obvious scale of scale，In the short term, other countries cannot replace。Fifth，China's production and labor costs and relative advantages，Complete category mature manufacturing technology and sufficient technology talent resources，It laid a sufficient foundation for the continuous development of Chinese raw materials and medicines。Sixth，Chinese companies avoid homogenization competition，The efforts of developing characteristic raw materials，and many companies aim at the market of developed countries，Actively pass the high -end market certification，Practice to continuously improve the quality of export products，The export space of Chinese raw materials will be expanded。
In short，2010，China's raw and drug opportunities and challenges co -deposited，But with the continuous recovery of the world economy，and the continuous introduction and implementation of the country's encouragement of export policies，We expect，2010 Chinese raw material exports may maintain a growth of about 15%。
The development of Chinese raw materials is always full of hope，The Medical Insurance Chamber of Commerce will continue to strengthen coordination and service，To promote the sustainable and healthy development of the production and trade of China's raw materials。
